A second California Assembly committee on Tuesday approved a Senate-passed bill to legalize possession of psychedelics like psilocybin and and LSD. But new amendments that add limits on allowable amounts of the substances is creating controversy among advocates.
The Assembly Public Health Committee advanced the legislation, sponsored by Sen. Scott Wiener (D), in a 8-4 vote. This comes weeks after the Public Safety Committee approved the measure.
Wiener has spent significant energy building support for the reform proposal as it has moved through the full Senate and now two Assembly committees, including by holding a recent rally with military veterans, law enforcement and health officials.
SB 519 would remove criminal penalties for possessing numerous psychedelicsincluding psilocybin mushrooms, DMT, ibogaine, LSD and MDMAfor adults 21 and older.
Our racist and failed war on drugs and war on drug policy approach has done nothing to make us safer, Assemblymember Buffy Wicks (D), who presented the bill on behalf of Weiner, said ahead of the vote. But its led to massive public expenditures, torn apart communities, deeply impacted brown and black communities and did nothing to make drug use safer or reduce overdoses. Indeed, the opposite is true.
Its time we stopped this failed mass incarceration strategy and acknowledge that not all substances are harmful or dangerous, she said. In fact, quite the opposite has been found of psychedelics.
Now, as a result of changes approved by the latest panel, the bill includes language laying out the limits for what is an allowable personal possession amount for each substance. Thats led Decriminalize Nature (DN), a group thats worked to enact psychedelics reform across the country, to call for the tabling of the legislation.
Setting allowable amounts is just a creative way to say when can law enforcement arrest you, DN argued.
In a letter about its boards recent decision to switch from a supportive position on the legislation to neutral, DN listed several reasons not to include the possession limits provision. Beyond enabling law enforcement to penalize people possessing certain amounts of entheogenic substances, it also said the measure has sacred value for communities whove used them for centuries and local decriminalization initiatives without possession limits have had no negative impacts.
But other advocates say they are taking a practical position on the revision, accepting the possession limits in the interest of advancing the reform through a legislature that may otherwise defeat the bill if it contained no such restrictions.
David Bronner, CEO of the soap company Dr. Bronners who has contributed considerable financial resources to reform efforts across the country, is one such advocate.
As always, do we let the perfect be the enemy of the good? he said in an email. Senator Wiener is doing an amazing job for us, and we are able to preserve the essential goal that people can heal in ceremony together, and legally produce and consume quantities of the medicine adequate for community-based healing. And theres nothing stopping local city level efforts that have no limiting language whatsoever.
Bronner said that stakeholders discussed the changes extensively, and Decriminalize Nature had full chance to input and review, and we all would have been beyond psyched if their eloquent defense of not having any limits whatsoever could convince the Health Committee chair, but it was unlikely and it hasnt.
As passed in committee on Tuesday, these are the prescribed limits for personal possession that would be legalized:
-2 grams of DMT
-15 grams of ibogaine
-0.01 grams of LSD
-4 grams of mescaline
-2 grams of the controlled substance psilocybin or 4 ounces of a plant or fungi containing the controlled substance psilocybin.
-2 grams of the controlled substance psilocyn or 4 ounces of a plant or fungi containing the controlled substance of psilocyn
-4 grams of MDMA.
It should be noted that while personal possession limits would be imposed under the revision, facilitators could have aggregate amounts for group use, meaning they could possess the allowable amount for each individual involved in a ceremony. And when it comes to personal cultivation, there would not be any limits.
SB 519 still represents protection of community-based healing and the quantities of medicine involved, which is the crucial goal, Bronner said.
Responding to accusations from DN that the possession limits are part of a plot to help deep-pocketed investors corner the market for psychedelics, Bronner said there are no backroom deals going on and that DN has been fully looped real time as weve been navigating this.
While social sharing would have been allowed under the bill as introduced, those provisions were also reframed in the new committee amendment to provide for facilitated or support use so that people could provide the substances to one another in a group context.
The new amendment adopted on Tuesday also requires the state Department of Public Health to develop harm reduction education for the substances.
In the prior Assembly panel, Wiener supported a committee amendment that removed ketamine from the list of psychedelics included in the reform. Thats in addition to a series of technical revisions that were made to the legislation.
The fullSenate approved the bill last month. It now heads to the Assembly Appropriations Committee as its final stop before potentially heading to the floor of that chamber. If approved there, it will have to go back to the Senate for concurrence on recent changes before it can be sent to the governors desk
Wiener has described its prospects going forward as very challenging, but he made the case at a recent press event that it is a necessary policy change to advance mental health reform and end criminalization.
Under the measure, the state Department of Public Health would be required to establish a working group to study and make recommendations regarding possible regulatory systems that California could adopt to promote safe and equitable access to certain substances in permitted legal contexts. Those recommendations would be due by January 1, 2024.
For psilocybin specifically, the legislation would repeal provisions in California statute that prohibit the cultivation or transportation of any spores or mycelium capable of producing mushrooms or other material that contain the psychoactive ingredient.
Thebilloriginally included record sealing and resentencing provisions for people previously convicted of psychedelics possession offenses, but that language was removed in its last committee stop prior to the Senate floor vote as part of an amendment from the sponsor.
Marijuana Moment is already tracking more than 1,100 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they dont miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
Wiener said the reasoning behind that deletion was that the policy ended up generating a huge price tag based on a fiscal analysis, but it could be addressed in separate legislation if the main bill passes.
Speaking at an event hosted by the Psychedelic and Entheogen Academic Council (PEAC) last month, the senator said advancing the legislation would be first step toward decriminalizing all currently illicit drugs.He reiterated that point on Monday, stating that this bill is one step in the direction of ending the failed war on drugs.
While the bill is being described by lawmakers and advocates as simple decriminalization, the official legislative analysis of the proposal states that it would make lawful the personal possession of these substances.
If the bill does ultimately clear the Assembly, it still remains unclear whether Gov. Gavin Newsom (D) would sign itthough the governor has long been an outspoken critic of the war on drugs.
Wiener backed the prior ketamine-related amendment in an effort to build support for the legislation.
There are disagreements within the psychedelic world on it, the senator said at a meeting with activists last month. My view as you keep things in until you have to make a give, and thats one that we could potentially give on. You dont want to spontaneously give on things without getting some ability to move the bill forward as a result.
Mescaline, a psychoactive compound derived from peyote and other cacti, is another controversial psychedelic.
It was specifically excluded from the bills reform provisions in peyote-derived form, but the possession of the compound would be allowed if it comes from other plants such as the Bolivian Torch Cactus, San Pedro Cactus, or Peruvian Torch Cactus.
That decision on the peyote exclusion was informed by native groups who havestrongly pushed back against decriminalizing the cactifor conservationist reasons and because of its sacred value for their communities.
Meanwhile, a group of California activists announced plans earlier this year to put aninitiative to legalize the use and retail sale of psilocybinon the states 2022 ballot. That group, Decriminalize California, said that it would first work to convince lawmakers to pursue reform and then take the issue directly to the people if the legislature fails to act.
The psychedelics effort in the California legislature, whichWiener first previewed back in November, comes as activists are stepping up the push to enact psychedelics reform locally in cities in the state and across the country. The bill notes those efforts in an explanation of the proposal.
The Northampton, Massachusetts City Councilpassed a resolutionin Aprilto deprioritize enforcement of laws against the possession, use and distribution of a wide range of psychedelics such as psilocybin and ayahuasca. Its the third city in the state to advance the policy change, followingSomervilleandCambridge.
These are some of the latest iterations of a national psychedelics reform movement thats spread rapidly sinceDenver became the first city to decriminalize psilocybin mushroomsin 2019.
Besides the cities in Massachusetts, four othersOakland,Santa Cruz,Ann ArborandWashington, D.C.have also decriminalized possession of plant-and fungi-based psychedelics.
In Oregon, Novembers election saw the passage of a historic initiatives tolegalize psilocybin mushrooms for therapeutic purposesand more broadlydecriminalize possession of all drugs.
The governor of Connecticut signed legislation recently that includes language requiring the state to carry out a study into the therapeutic potential of psilocybin mushrooms.
Texas also recently enacted a bill to require the statestudy the medical benefits of psychedelics for military veterans.
A New York lawmaker introduced a bill last month that would require the state to establish an institute to similarly research the medical value of psychedelics.
In Oakland, the first city where a city council voted to broadly deprioritize criminalization of entheogenic substances, lawmakersapproved a follow-up resolutionin December that calls for the policy change to be adopted statewide and for local jurisdictions to be allowed to permit healing ceremonies where people could use psychedelics.
After Ann Arbor legislators passed a decriminalization resolution last year, a county prosecutor recently announcedthat his office will not be pursuing chargesover possessing entheogenic plants and fungiregardless of the amount at issue.
The Aspen, Colorado City Councildiscussed the therapeutic potential of psychedelics like psilocybin and proposals to decriminalize such substances at a meeting in May. But members said, as it stands, enacting a reform would be more better handled at the state level while entheogens remain strictly federally controlled.
Seattle lawmakers also recently sent a letter to members of a local task force focused on the opioid overdose epidemic, imploring the group toinvestigate the therapeutic potential of psychedelicslike ayahuasca and ibogaine in curbing addiction.
Biden Selects White House Drug Czar Who Helped Implement State Marijuana Program And Touted Medical Benefits
Photo courtesy of Wikimedia/Workman.
Go here to see the original:
- Yale researchers using psychedelics to find new treatments for depression - WTNH.com - September 17th, 2021
- Want Quick Exposure To The Psychedelics Sector? Check Out This New Active ETF - Benzinga - Benzinga - September 17th, 2021
- 5 things to know about the Ann Arbor psychedelic shroom fest - MLive.com - September 17th, 2021
- A Look At Psychedelics Stock PharmaTher And Its Recent Bull Run - Benzinga - Benzinga - September 17th, 2021
- Differentiated Approach in Psychedelics Boosts Confidence in Upcoming Clinical Trials for Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) -... - September 17th, 2021
- Psychedelics research and public education elevated by multiple gifts - UC Berkeley - September 16th, 2021
- Pain Awareness Month: Psychable Educates Patients on Transformative Power of Using Psychedelics as Medicine for Pain Treatment, Management and Healing... - September 16th, 2021
- $80 Million Granted to Research Psychedelic Properties of Ingesting Toad Venom - Newsweek - September 16th, 2021
- Psychedelic Use on the Rise As Gen Z Seeks To Enhance Connectedness - VICE UK - September 16th, 2021
- Phyto Partners Cannabis VC on Why He's Investing in Psychedelics - Business Insider - September 16th, 2021
- Detroit Voters Will Decide On Psychedelics Decriminalization Ballot Measure In November - Marijuana Moment - September 16th, 2021
- Seattle bid to decriminalize psychedelics could have profound effect on treating addiction - MyNorthwest.com - September 16th, 2021
- Post-9/11 vets go to Mexico to treat trauma with psychedelic - The San Diego Union-Tribune - September 16th, 2021
- Lobe Sciences to Participate at the Advances in Me... | INN - Investing News Network - September 16th, 2021
- Seattle is now in the process of legalizing psychedelics, heres what to know - Curiocity - September 16th, 2021
- World Suicide Prevention Day: Suicide Remains a Leading Global Cause of Death; Communities Across the World Seek Expanded Use of Psychedelics as... - September 16th, 2021
- Psilocybin Transdermal Patches Could Be The Next Big Thing In Psychedelics - Forbes - September 1st, 2021
- Psychedelics are getting closer to approval, but the market may not be ready - FierceBiotech - August 22nd, 2021
- At-Home Genetic Testing Cant Tell You If Youre Going to Have a Bad Trip - VICE - August 22nd, 2021
- Past, Present & Future of Psychedelic-Assisted Therapy: A New Dawn for Mental Health and Neuroscience - cmc.edu - August 22nd, 2021
- Researchers breaking away from the central dogma of depression - STAT - STAT - August 22nd, 2021
- When did humans start experimenting with alcohol and drugs? - EL PAS in English - August 22nd, 2021
- Origin Therapeutics Will Invest $5.1M In Psychedelics Startups - Yahoo Finance - August 14th, 2021
- GR is getting close to decriminalizing psychedelic plants and fungi - Fox17 - August 14th, 2021
- PsychedelicNewsBreaks Microdose Psychedelic Insights to Deep Dive into World of Psychedelic Medicine Investment at Upcoming Conference -... - August 14th, 2021
- Bexson Biomedical Launches New Project, Applying Subcutaneous Delivery Technology To Multiple Psychedelic Compounds For Therapeutic Use - PRNewswire - August 14th, 2021
- Neil deGrasse Tyson Talks Psychedelic Mushrooms And The Weird World Of Fungi On His Podcast - IFLScience - August 14th, 2021
- Delic Announces Luke Storey, Transformation Coach and Creator/Host of Thought-Provoking Podcast, The Life Stylist to Speak at Meet Delic: The World's... - August 14th, 2021
- Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) CEO Shares Insights on the Psychedelics Space on The Dealmaker Podcast - StreetInsider.com - August 14th, 2021
- Cybin Inc. Announces 2021 First Quarter Financial Results and Business Highlights - Business Wire - August 14th, 2021
- Biomind Labs Files Patent Application in the United States Patent and Trademark Office, Its 4th Patent Application - Yahoo Finance - August 14th, 2021
- Researchers Concerned About Whitewashing of Psychedelic-Assisted Mental Health Research - Mad In America - James Moore - August 6th, 2021
- Cybin Becomes First Psychedelics Company On The NYSE: CEO Explains Everything You Need To Know - Yahoo Finance - August 6th, 2021
- Guide to the psychedelics industry: Companies, investors, science - Business Insider - August 6th, 2021
- Three Additional Cities Across The Country Are Considering Decriminalizing Psychedelics - Yahoo Finance - August 6th, 2021
- Taking psychedelics while on lithium may increase risk of seizures, bad trips: study - The GrowthOp - August 6th, 2021
- B.C. non-profit challenges Health Canada to end 50-year prohibition on magic mushrooms - CBC.ca - August 6th, 2021
- First-ever research centre for psychedelic drug therapy is opening in Australia - Mixmag - August 6th, 2021
- New poll shows a strong base of Canadians overwhelmingly support controlled legal access to psilocybin-assisted - GlobeNewswire - August 6th, 2021
- Could psychedelic drugs revolutionise mental health care in the UK? - ITV News - August 6th, 2021
- Filament Health is the First Public Company to be Issued a Patent for Extraction of Natural Psilocybin - Yahoo Finance - August 6th, 2021
- Are Psychedelics Legal In The US? Where Are They Decriminalized? A Deep Dive Into The Legal Status of Psilocybin, MDMA, LSD, Ketamine And More - Yahoo... - August 2nd, 2021
- Banfield: Experts weigh in on the often misunderstood world of psychedelics - NewsNation Now - August 2nd, 2021
- Vancouver company receives federal licence to work with all natural psychedelics, including ayahuasca - The GrowthOp - August 2nd, 2021
- At one with the universe: How can psychedelic drugs help treat suffering? - Sydney Morning Herald - August 2nd, 2021
- Analysis Suggests No Link Between Psychedelics and the Onset of Mental Health Conditions - StreetInsider.com - August 2nd, 2021
- Nasdaq-listed MindMed Launches Human Trials OnDMT, The Psychedelic Ingredient In Ayahuasca - Forbes - August 2nd, 2021
- MindMed Leverages Ayahuasca's Ingredient DMT In Psychedelic-Inspired Therapies, Launches Trials With 30 Subjects - Markets Insider - August 2nd, 2021
- A trip to the doctor: A personal experience of how psychedelics are transforming mental health therapies - The Monthly - August 2nd, 2021
- Johns Hopkins Scientists Give Psychedelics the Serious ... - July 25th, 2021
- Psychedelics Get a New Look, and PTSD Sufferers Might Have ... - July 25th, 2021
- Why Seelos Therapeutics Stock Is Jumping Today | The ... - July 25th, 2021
- Psychedelic trips could soon be part of therapy heres what those sessions will look like - CNBC - July 25th, 2021
- AOC Promotes Research On Benefits Of Psychedelics Like Psilocybin And MDMA With New Amendment - Marijuana Moment - July 25th, 2021
- Michael Pollan on psychedelics and Americas dysfunctional relationship with drugs - Vox.com - July 25th, 2021
- Is It Too Early to Invest in Psychedelic Stocks? - The Motley Fool - July 25th, 2021
- Can Psychedelics Be Used to Treat Fibromyalgia? - Pain News Network - July 25th, 2021
- Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness - PRNewswire - July 25th, 2021
- Doctors treating depression see promise in ketamine, a cheap drug already approved for anesthesia - ABC News - July 25th, 2021
- Cybin Lands Conditional Approval To Become The First Psychedelics Company on The NYSE - Markets Insider - July 25th, 2021
- Will Psychedelics Continue To Grow In 2021? Fund Managers Share Insights And Strategies As More Companies - Benzinga - July 25th, 2021
- Microdose Psychedelic Insight's Psychedelic Capital: July 2021 conference to take place on July 29, 2021 - StreetInsider.com - July 25th, 2021
- 'I Tried Psychedelics to Treat My Debilitating Cluster Headaches' - Prevention.com - July 18th, 2021
- Florida startup treating illness with magic mushrooms receives $2.5 million - The Register-Guard - July 18th, 2021
- Psychedelic microdosing study to reveal what really happens in brains - Macquarie University - July 18th, 2021
- Another Psychedelic and Its Potential Psychiatric Promise - Technology Networks - July 18th, 2021
- MindMed Studies the Role of Psychedelics in Treatments - TechAcute - July 18th, 2021
- LSD and nicotine could be more important to healthcare than we think - Euronews - July 18th, 2021
- Ready to Tap into the US$7.6 billion Psychedelics Market - Stockhouse - July 18th, 2021
- Triple Your Money in 6 Months With This Top Biotech Stock to Buy Right Now - InvestorPlace - July 18th, 2021
- The Newly Institute Announces the Execution of a Joint Working Agreement with Drug Science for the Drug Science Medical Psychedelics Working Group -... - July 18th, 2021
- Cybin to Participate in Grizzle Psychedelics Con on June 28th - Business Wire - June 28th, 2021
- California State Senate Passes Psychedelic Legalization In Latest Wave Of The New Psychedelic Revolution - Cannabis & Hemp - United States -... - June 28th, 2021
- Goodness Growth Holdings Subsidiary Resurgent Biosciences Files Patent for Virtual Reality Applications to Facilitate Therapeutic Psychedelic... - June 28th, 2021
- Why This MindMed Analyst Is Bullish: 'One Of The Most Diverse Pipelines In Psychedelics' - Benzinga - Benzinga - June 28th, 2021
- New TX Law Allows for Study of Psychedelics as Treatment for Veterans with PTSD - WBAP News/Talk - June 28th, 2021
- What It Means To Live 'Psychedelically:' DoubleBlind Mag #05 Dives Deep Into The Topic - Benzinga - Benzinga - June 28th, 2021
- Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange - Business Wire - June 28th, 2021
- Atai Goes Public With Promising New Mental-Health Treatments Based On Psychedelics - Entrepreneur - June 28th, 2021
- Crypto, Cannabis Backers Turn to Psychedelics With New UK IPO - Bloomberg - June 11th, 2021